Both in Pharmaceuticals
GRI Bio vs Medicus Pharma
Over the past year GRI returned −96.8% and MDCX returned −98.5%; their daily moves had a correlation of 0.06.
GRI −96.8% MDCX −98.5%Growth of $1, one year, split-adjusted
| Metric | GRI | MDCX |
|---|---|---|
| Price | $1.53 | $1.88 |
| Market cap | $3.3M | $2.7M |
| Today | −2.55% | −12.56% |
| 1 month | −21.9% | −76.1% |
| 6 months | −29.8% | −86.8% |
| Year to date | −77.9% | −97.5% |
| 1 year | −96.9% | −98.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 134.4% | 1,166.3% |
| Short % of float | 3.0% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).